People · Operator
Named in public records as an officer, director or promoter · active 2015–2020 · Biotechnology, AI / ML
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Juno Therapeutics, Inc. | — | Biotechnology | Growth/Late | $1.1B | $1.3B | 2015 |
| Tanium Inc. | — | AI / ML | Series D+ | $911.8M | $5.8B | 2017 |
| Docusign, Inc. | — | AI / ML | Series D+ | $476.5M | $1.5B | 2020 |
Mary Agnes Wilderotter at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mary Agnes Wilderotter on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Nelsen | 1 | 22 |
| Ben Horowitz | 1 | 15 |
| Rory O'Driscoll | 1 | 15 |
| Enrique Salem | 1 | 12 |
| Bryan Taylor | 1 | 9 |
| MARK FIELDS | 1 | 8 |
| Richard Klausner | 1 | 7 |
| Keith Krach | 1 | 6 |
| Anthony Evnin | 1 | 6 |
| Jonathan Roberts | 1 | 5 |
| Eric Brown | 1 | 5 |
| David R. Lee | 1 | 5 |
| Steve King | 1 | 5 |
| Peter Solvik | 1 | 5 |
| Matthew Schiltz | 1 | 4 |
| Scott Darling | 1 | 4 |
| Pete Solvik | 1 | 4 |
| Mike Dinsdale | 1 | 3 |
| Enrique T. Salem | 1 | 3 |
| Mary Meeker | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.